Alexis R. Papariello

Alexis R. Papariello

Auto-generated profile, based on publicly available information

Alexis R. Papariello

Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in ASSAY and Drug Development Technologies
Verified
Journal Article
Closed access
APAlexis Papariello
Alexis Papariello
KLKaren A. Litwa
Karen A. Litwa
Human-derived neurons and brain organoids have revolutionized our ability to model brain development in a dish. In this review, we discuss the potential for human brain models to advance drug discovery for complex neuropsychiatric disorders. First, we address the advantages of human brain models to screen for new drugs capable of altering CNS activity. Next, we propose an experimental pipeline for using human-derived neurons and brain organoids to rapidly assess drug impact on key events in brain development, including neurite extension, synapse formation, and neural activity. The experimental pipeline begins with automated high content imaging for analysis of neurites, synapses, and neuronal viability. Following morphological examination, multi-well microelectrode array technology examines neural activity in response to drug treatment. These techniques can be combined with high throughput sequencing and mass spectrometry to assess associated transcriptional and proteomic changes. These combined technologies provide a foundation for neuropsychiatric drug discovery and future clinical assessment of patient-specific drug responses.

21 November 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
ARAnthony D. Ramnauth
Anthony D. Ramnauth
MTMadhavi Tippani
Madhavi Tippani
HDHeena R. Divecha
Heena R. Divecha
APAlexis R. Papariello
Alexis R. Papariello
RMRyan A. Miller
Ryan A. Miller
SPStephanie C. Page
Stephanie C. Page
The dentate gyrus of the anterior hippocampus is important for many human cognitive functions, including regulation of learning, memory, and mood. However, the postnatal development and aging of the dentate gyrus throughout the human lifespan has yet to be fully characterized in the same molecular and spatial detail as other species. Here, we generated a spatially-resolved molecular atlas of the dentate gyrus in postmortem human tissue using the 10x Genomics Visium platform to retain extranuclear transcripts and identify changes in molecular topography across the postnatal lifespan. We found enriched expression of extracellular matrix markers during infancy and increased expression of GABAergic cell-type markers GAD1, LAMP5, and CCK after infancy. While we identified a conserved gene signature for mouse neuroblasts in the granule cell layer (GCL), many of those genes are not specific to the GCL, and we found no evidence of signatures for other granule cell lineage stages at the GCL post-infancy. We identified a wide-spread hippocampal aging signature and an age-dependent increase in neuroinflammation associated genes. Our findings suggest major changes to the putative neurogenic niche after infancy and identify molecular foci of brain aging in glial and neuropil enriched tissue.

31 October 2025 in bioRxiv
Verified
Preprint
Open access
BMBernard Mulvey
Bernard Mulvey
HDHeena R. Divecha
Heena R. Divecha
MTMadhavi Tippani
Madhavi Tippani
SBSvitlana V. Bach
Svitlana V. Bach
RBRahul Bharadwaj
Rahul Bharadwaj
KMKeri Martinowich
Keri Martinowich
The locus coeruleus (LC) is a small noradrenergic nucleus in the dorsal pons that sends projections across the brain regulating sleep, arousal, attention, stress responses, and some forms of cognition. LC neurons show pathology in the earliest stages of Alzheimer’s disease (AD), including age-related accumulation of hyperphosphorylated tau (pTau) and accelerated loss of neuromelanin (NM) pigmentation. NM-sensitive neuroimaging of the LC predicts previous cognitive decline, clinical severity, and future AD progression. While these findings suggest that the LC plays an etiologic role in AD, the molecular landscape of the LC prior to clinical manifestation of sporadic AD remains largely uncharacterized. This information is critical for developing interventions that preserve LC integrity and function. We performed spatially-resolved transcriptomics on 85 sections of human postmortem LC from N =33 neurotypical middle-aged donors, balanced for epidemiologic AD risk factors including sex, African or European ancestry, and APOE genotype (carriers of the E4/risk or E2/protective alleles). Comparing across APOE genotypes, we find astrocytic gene expression differences proximal to LC neurons. Associating NM content with local gene expression, we show that higher overall APOE gene expression correlates with reduced NM content and an enrichment of NM-associated genes in aging pathways. Unexpectedly, we find enriched LC expression of cholesterol synthesis genes, alongside evidence for lipid synthesis gene regulatory network activity in NM-containing LC specifically, revealing a potential intersection between intrinsic lipid metabolism in LC neurons, NM, and the role of APOE-mediated lipid biology in AD. Together, these data illuminate the molecular features of the human LC at spatial resolution with unprecedented sampling depth, revealing how AD risk factors and NM content influence resilience and susceptibility of this critical brain nucleus to pathology accumulation and degeneration.

11 September 2026 in Acta Neuropathologica
Verified
Journal Article
Closed access
PDF file
BMBernard Mulvey
Bernard Mulvey
HDHeena R. Divecha
Heena R. Divecha
MTMadhavi Tippani
Madhavi Tippani
SBSvitlana V. Bach
Svitlana V. Bach
RBRahul Bharadwaj
Rahul Bharadwaj
KMKeri Martinowich
Keri Martinowich